Article
SALL4B not targeted by IMiD is important for SALL4-mediated tumorigenesis
2023-07-07
Abstract excerpt
Immunomodulatory (IMiD) drugs have shown prominent therapeutic activity in hematologic malignancies; however, their use in solid tumors is limited. The oncofetal protein SALL4 is essential for cancer cell survival. While IMiDs can induce SALL4 degradation, they fail to induce cell death in SALL4-expressing cancer cell lines. Here, we observed that this inefficacy arose from their selective degradation of the long...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3100a6e3-062a-5d20-aed4-a0193191d3c9
- DOI
- 10.1101/2023.07.07.548071
